ctrl K

Price Alert

EyeGate Pharmaceuticals I... (EYEG)

NASDAQ: EYEG · Real-Time Price · USD

35.63

-0.08 (-0.22%)

At close: Aug 18, 2025, 3:06 PM

35.65

0.05%

After-hours: Aug 18, 2025, 04:04 PM EDT

EyeGate Pharmaceuticals Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	n/a	16M	n/a	20K	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	-20K	n/a	20K	n/a	n/a	n/a
Operating Income	-2.33M	9.11M	-3.6M	-2.54M	-2.97M	-2.75M	-2.58M
Interest Income	n/a	1.25M	n/a	n/a	n/a	332.00	250.00
Pretax Income	-2.07M	14.26M	-3.41M	-2.22M	-2.97M	-2.47M	-2.58M
Net Income	-2.19M	16.33M	-3.41M	-2.22M	-2.97M	-2.47M	-2.58M
Selling & General & Admin	1.49M	1.28M	1.38M	1.54M	1.34M	1.31M	1.3M
Research & Development	2.53M	3.99M	1.32M	906.68K	1.63M	1.44M	1.28M
Other Expenses	n/a	n/a	904.01K	120.23K	n/a	n/a	n/a
Operating Expenses	4.02M	5.27M	3.6M	2.56M	2.97M	2.75M	2.58M
Interest Expense	n/a	-21.45K	n/a	n/a	n/a	2.03K	686.00
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	5.27M	3.6M	2.56M	2.97M	2.75M	2.58M
Income Tax Expense	-123.01K	-2.07M	n/a	n/a	259.00	n/a	250.00
Shares Outstanding (Basic)	4.22M	3.87M	4.21M	4.17M	7.06M	7.06M	6.95M
Shares Outstanding (Diluted)	4.22M	4.13M	4.21M	4.17M	7.06M	7.06M	6.95M
EPS (Basic)	-0.52	2.69	-0.81	-0.53	-0.42	-0.35	-0.37
EPS (Diluted)	-0.52	2.63	-0.81	-0.53	-0.42	-0.35	-0.37
EBITDA	-2.33M	14.23M	-3.6M	-2.54M	-2.96M	-2.45M	-2.57M
EBIT	n/a	n/a	n/a	n/a	-2.97M	-2.47M	-2.58M
Depreciation & Amortization	n/a	-11.06K	n/a	n/a	11.06K	12.6K	10.6K